Fasting-mimicking diet shows unique benefits in cardiovascular health, study finds

Study compares the fasting-mimicking diet and the Mediterranean diet in reducing cardiovascular disease risk among obese adults with hypertension, revealing unique benefits of each diet.

Pharma has over $500B in capital for deals

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we

May 8, 2024

Changes in prescribing practices and parental awareness contribute to teen drug decline

Since 2009, U.S. high school seniors have reported steep declines in medical use, misuse and availability of the three most commonly prescribed and misused controlled

July 25, 2024

Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint – Pharmaceutical Technology

The AUGMENT-101 trial evaluated the safety and efficacy of revumenib in adults with relapsed or refractory mutant NPM1 AML. Credit: SeventyFour via Shutterstock. Syndax Pharmaceuticals

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.